SEARCH · Engineering Papers
Results for “pharmaceutics”
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Performance Characteristics of Mass Spectrometry-Based Analytical Procedures for Quantitation of Nitrosamines in Pharmaceuticals: Insights from an Inter-laboratory Study
Not Available
A practical guide to pharmaceutical analyses using X-ray powder diffraction
Abstract not provided
Selective Imaging of Active Pharmaceutical Ingredients in Powdered Blends with Common Excipients Utilizing Two-Photon Excited Ultraviolet-Fluorescence and Ultraviolet-Second Order Nonlinear Optical Imaging of Chiral Crystals
Explore the source record for details and available documents.
Crystallization Propensity of Amorphous Pharmaceuticals: Kinetics and Thermodynamics
Explore the source record for details and available documents.
Excipient-Induced Lattice Disorder in Active Pharmaceutical Ingredient: Implications on Drug Product Continuous Manufacturing
Not provided.
Correlation between Molecular Mobility and Physical Stability in Pharmaceutical Glasses
Abstract not provided
Effect of Water on Molecular Mobility and Physical Stability of Amorphous Pharmaceuticals
In this work, we investigated the influence of sorbed water concentration on the molecular mobility and crystallization behavior in a model amorphous drug and a solid dispersion. The temperature scaling ($T_g/T$) allowed us to simultaneously evaluate the effects of water content and temperature on the relaxation time. In the supercooled dispersions, once scaled, the relaxation times of the systems with different water content overlapped. Thus, the observed increase in mobility could be explained by the “plasticization” effect of water. This effect also explained the decrease in crystallization onset temperature brought about by water. That is, plasticization is the underlying mechanism governing the observed increase in mobility and physical instability in the supercooled state. Similar results were observed in the glassy drug substance. A single linear relationship was observed between crystallization time (time for 0.5% crystallization) and $T_g/T$ in both dry and water containing systems. Since fragility is unaffected by modest amounts of water, much like crystallization time, the mobility in the glass is expected to scale with $T_g$.
Crystallization Optimization of Pharmaceutical Solid Forms with X-ray Compatible Microfluidic Platforms
Abstract not provided
Influence of Molecular Mobility on the Physical Stability of Amorphous Pharmaceuticals in the Supercooled and Glassy States
Abstract not provided
Experimental Limiting Oxygen Concentrations for Nine Organic Solvents at Temperatures and Pressures Relevant to Aerobic Oxidations in the Pharmaceutical Industry
Not Available
Heterogeneous estimations of non-pharmaceutical mitigation behavior during the COVID-19 pandemic
The COVID-19 pandemic highlighted the importance of human behavior in mitigating the spread of disease. Nonetheless, human behavior is often overlooked in models of disease spread, particularly by underutilizing real-world data. We address this by estimating probabilities that individuals engage in behaviors that influence SARS-CoV-2 transmission risk during the COVID-19 pandemic, between September 2020 and June 2022. These behaviors include wearing a mask, using public transportation, spending time with others, avoiding contact with others, and going to work. Our estimates account for the age and sex of individuals and are generated for every county in the United States. We utilized multiple open-source datasets and United States Census data to produce these estimates. Multiple datasets were used for validation, showing our estimates demonstrated comparable accuracy and robustness. Our estimates aid in understanding human behavior dynamics during the COVID-19 pandemic and could be used to inform monthly or longer-term behavior in simulations of COVID-19. Moreover, the methods presented can be applied to other behaviors and features for future simulations of infectious disease.
Polymorphism control of an active pharmaceutical ingredient beneath calixarene-based Langmuir monolayers
Abstract not provided
Quantitative carbon detector for enhanced detection of molecules in foods, pharmaceuticals, cosmetics, flavors, and fuels
Analysis of trace compounds, such as pesticides and other contaminants, within consumer products, fuels, and the environment requires quantification of increasingly complex mixtures of difficult-to-quantify compounds.
Solvent compatible microfluidic platforms for pharmaceutical solid form screening
Abstract not provided
A refined phase diagram of the tert -butanol–water system and implications on lyophilization process optimization of pharmaceuticals
In TBA–water mixtures, using DSC and XRD, the eutectic temperature (-8 °C) and composition (22.5% w/w TBA) were determined.